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Summary
Background.  —  No  previous  study  has  looked  for  an  association  between  aortic  dilatation  and
the clinical  sequelae  of  patent  foramen  ovale  (PFO),  although  a  possible  relationship  has  been
identiﬁed  in  case  reports.
Aim.  —  To  compare  aortic  dimensions  in  patients  with  symptomatic  PFO  and  healthy  controls.
Methods.  —  Forty-seven  patients  were  identiﬁed  who  presented  with  cryptogenic  cerebrovas-
cular accident  (CVA)  assessed  as  most  likely  secondary  to  PFO  (conﬁrmed  by  contrast  study),
were aged  less  than  50  years  and  underwent  percutaneous  PFO  closure.  Forty-seven  age-,  sex-
and body  surface  area-matched  healthy  controls  were  also  identiﬁed.
Results.  —  Aortic  root  diameters  were  greater  in  PFO  patients.  The  difference  was  more  marked
at the  levels  of  the  sinuses  of  Valsalva  (34  ±  4  vs  31  ±  3  mm,  P  <  0.01)  and  the  proximal  ascending
aorta (32  ±  4  vs  29  ±  3,  P  <  0.01)  and  more  modest  at  the  level  of  the  aortic  annulus  (23  ±  3  vs
22 ±  2  mm,  P  =  0.20).  In  addition,  patients  with  massive  right-to-left  shunting  tended  to  have
larger aortic  diameters.  In  contrast,  left  ventricular  end-systolic  and  end-diastolic  diameters
were not  larger  than  in  controls  (30  ±  4  vs  32  ±  5  mm,  P  =  0.10  and  48  ±  5  vs  50  ±  4  mm,  P  =  0.04,
respectively).
Abbreviations: ASA, atrial septal aneurysm; BSA, body surface area; CVA, cerebrovascular accident; IAS, interatrial septum; PFO,
patent foramen ovale; TTE, transthoracic echocardiography.
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Conclusion.  —  The  present  study  shows  that  aortic  diameter  is  increased  in  young  patients  with
cryptogenic  CVA  and  PFO  compared  with  in  healthy  subjects.  Our  results  suggest  that  aortic
dilatation  may  potentiate  the  risk  of  CVA  in  PFO  patients  and  support  further  research  in  this
area.
© 2011  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  Il  n’existe  pas  d’étude  ayant  évalué  la  relation  entre  la  taille  de  l’aorte  ascen-
dante et  la  présence  d’un  foramen  ovale  perméable  (FOP)  symptomatique,  même  si  une  telle
association  a  été  suggéré  dans  des  cas  cliniques.
Objectifs.  — Le  but  de  cette  étude  était  de  comparer  les  dimensions  de  l’aorte  chez  des  patients
avec un  FOP  ayant  présenté  un  accident  vasculaire  cérébral  (AVC)  et  chez  des  sujets  sains.
Méthodes.  — Nous  avons  inclus  47  patients  ayant  :  1  :  présenté  un  AVC  sans  autre  cause  retrouvé
qu’un FOP  conﬁrmé  par  épreuve  de  contraste  ;  2  :  agés  de  moins  de  50  ans  et  ;  3  : ayant  bénéﬁcié
d’une fermeture  percutanée  du  FOP  et  47  sujets  sains  comme  contrôles  appariés  pour  l’âge,  le
sexe et  la  surface  corporelle.
Résultats.  —  Les  diamètres  aortiques  etaient  signiﬁcativement  plus  large  chez  les  patients  avec
FOP que  chez  les  contrôles.  Les  différences  étaient  surtout  marquées  au  niveau  des  sinus  de
Valsalva (34  ±  4  vs  31  ±  3  mm,  p  <  0,01)  et  de  l’aorte  tubulaire  (32  ±  4  vs  29  ±  3,  p  <  0,01)  et  moins
au niveau  de  l’anneau  (23  ±  3  vs  22  ±  2  mm,  p  =  0,20).  Les  patients  avec  un  shunt  important
présentaient  également  des  dimensions  aortique  plus  importantes.  À  l’inverse,  les  dimensions
ventriculaires  n’étaient  pas  plus  large  chez  les  patients  que  chez  les  contrôles  (30  ±  4  vs  32  ±  5,
p =  0,10  et  48  ±  5  vs  50  ±  4  mm,  p  =  0,04,  respectivement).
Conclusions.  —  Cette  étude  montre  que  les  dimensions  aortiques  sont  plus  importantes  chez
les patients  avec  FOP  ayant  présenté  un  AVC  idiopathique  que  chez  les  sujets  contrôles.  Ces
résultats suggèrent  que  la  dilatation  aortique  pourrait  être  un  facteur  favorisant  d’AVC  chez
les patients  présentant  un  FOP  et  nécessite  des  études  complémentaires.
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atent  foramen  ovale  (PFO)  has  been  linked  with  an
ncreased  risk  of  cerebrovascular  accident  (CVA)  in  case-
ontrolled  studies  [1,2], especially  when  associated  with  an
trial  septal  aneurysm  (ASA)  [3,4]. However,  PFO  is  a  com-
on  ﬁnding  in  the  general  population  (up  to  25%)  [5,6]  and
actors  that  may  potentiate  the  risk  of  stroke  (in  addition
o  the  presence  of  a  PFO)  are  of  great  interest  [7—9]. Case
eports  [10—13]  and  one  retrospective  series  [14]  have  indi-
ated  a  possible  association  between  aortic  root  dilatation
particularly  aneurysm  formation)  and  right-to-left  shunt-
ng.  However,  no  previous  study  has  looked  for  an  association
etween  aortic  dilatation  and  the  clinical  sequelae  of  PFO.
hus,  the  aim  of  the  present  study  was  to  compare  aortic
imensions  in  patients  with  symptomatic  PFO  and  in  healthy
ontrols  hypothesizing  that  they  would  be  larger  in  patients
ith  PFO.
ethods
opulation
atients  who  have  undergone  PFO  closure  at  our  institution
re  enrolled  into  a  database,  which  was  reviewed  to  identify
atients  who  presented  with  cryptogenic  CVA  as  deﬁned  by
he  referring  neurologist,  had  a  PFO  conﬁrmed  by  a  transtho-
acic  echocardiography  (TTE)  contrast  study,  were  aged  less
d
p
t
as  droits  réservés.
han  50  years  and  underwent  percutaneous  PFO  closure.
he  database  was  reviewed  for  clinical  variables  including
eight,  weight,  body  surface  area  (BSA),  modiﬁable  cardio-
ascular  risk  factors,  history  of  migraine  and  the  presence  of
SA.  Patients  with  PFO  were  matched  for  age,  sex  and  BSA
ith  healthy  volunteers  (nurses,  medical  students,  physi-
ians)  with  no  previous  medical  history,  who  were  not  taking
ny  medication  and  had  no  modiﬁable  cardiovascular  risk
actors.
chocardiographic analysis
TE  was  performed  using  high-quality  commercially  avail-
ble  ultrasound  systems  (iE33  [Royal  Philips  Electronics,
msterdam,  The  Netherlands]  and  Vivid  7  [GE  Healthcare,
halfont  St.  Giles,  UK]).  A  PFO  was  considered  present  when
 contrast  test  with  agitated  saline  solution,  at  rest  and  dur-
ng  a  Valsalva  manoeuvre,  showed  an  interatrial  shunt  with
n  early  (within  three  cardiac  cycles)  opaciﬁcation  of  the
eft  atrium  [3].  ASA  was  deﬁned  as  an  interatrial  septum
IAS)  of  abnormal  mobility  with  protrusion  of  the  septum
nto  the  left  or  right  atrium  by  at  least  10  mm  beyond  the
aseline  [15]. Measurements  of  the  aortic  root  and  proximal
scending  aorta  were  made  retrospectively  using  the  same
ethodology  in  controls  and  patients,  from  two-dimensional
igitalized  images  and  videos  stored  on  the  network,  in  the
arasternal  long-axis  view,  perpendicular  to  the  long  axis  of
he  vessel,  from  leading  edge  to  leading  edge  by  one  oper-
tor.  Measurements  were  made  at  three  levels:  the  aortic
15
Figure 1. Scatterplots of diameters of (A) the aortic annulus, (B)
the sinuses of Valsalva and (C) the proximal ascending aorta, in con-
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annulus,  the  sinuses  of  Valsalva  and  the  proximal  ascending
aorta,  1  cm  above  the  sinotubular  junction.  As  is  conven-
tional,  the  aortic  annulus  diameter  was  measured  at  end
systole,  while  the  diameters  at  the  sinuses  of  Valsalva  and
in  the  proximal  ascending  aorta  were  measured  at  end  dias-
tole  [16,17].  In  addition,  left  ventricular  end-diastolic  and
end-systolic  diameters  were  measured  in  the  parasternal
long-axis  view  using  M-mode.
Statistics and ethics
Continuous  variables  are  expressed  as  mean  ±  standard  devi-
ation.  Comparisons  between  PFO  patients  and  controls  were
performed  using  the  t  test  or  the  Khi2 test,  as  appropri-
ate.  Variability  in  diameter  measurements  was  calculated
at  each  level  (aortic  annulus,  sinuses  of  Valsalva  and  prox-
imal  ascending  aorta)  as  the  absolute  difference  between
measurements  performed  weeks  apart  by  the  same  operator
(intraobserver  variability)  or  different  operators  (interob-
server  variability).  As  this  was  a  retrospective  analytical
study  and  the  patients  required  no  additional  investiga-
tions,  only  verbal  consent  was  obtained.  Healthy  controls
are  enrolled  in  an  ongoing  prospective  study.
Results
Baseline characteristics
Between  September  2006  and  July  2009,  47  PFO  patients
with  cryptogenic  CVA  and  PFO  met  the  enrolment  criteria
and  were  matched  with  47  healthy  controls.  The  character-
istics  of  both  populations  are  given  in  Table  1.  By  design,
there  were  no  signiﬁcant  differences  between  populations
in  terms  of  age,  sex,  height,  weight  or  BSA.  No  PFO  patient
was  hypertensive.  Nine  (19%)  PFO  patients  had  a  history  of
migraine,  35  (74%)  met  the  diagnostic  criteria  for  ASA  and
23  (49%)  had  massive  right-to-left  shunting,  as  indicated
by  the  passage  of  greater  than  30  microbubbles  sponta-
neously  without  a  Valsalva  manoeuvre  during  a  TTE  contrast
study.
Echocardiographic measurements
Aortic  root  diameters  were  greater  in  patients  with  PFO.
The  difference  was  more  marked  at  the  levels  of  the  sinuses
of  Valsalva  (34  ±  4  vs  31  ±  3  mm,  P  <  0.01)  and  the  prox-
imal  ascending  aorta  (32  ±  4  vs  29  ±  3  mm,  P  <  0.01);  the
difference  was  non-signiﬁcant  at  the  level  of  the  aortic
annulus  (23  ±  3  vs  22  ±  2  mm,  P  =  0.20)  (Fig.  1)  (Table  1).
In  contrast,  left  ventricular  diameters  were  not  greater  in
PFO  patients.  There  was  no  signiﬁcant  difference  in  left
ventricular  end-systolic  diameters  between  PFO  and  con-
trol  patients  (30  ±  4  vs  32  ±  5  mm,  P  =  0.10),  whereas  left
ventricular  end-diastolic  diameters  were  slightly  greater
in  healthy  controls  (48  ±  5  vs  50  ±  4  mm,  P  =  0.04).  Aortic
diameters  were  larger  in  patients  with  massive  right-to-left
shunting  than  in  those  with  more  modest  shunting  at  the
level  of  the  proximal  ascending  aorta  (33  ±  4  vs  30  ±  4  mm,
P  =  0.05)  but  not  at  the  levels  of  the  aortic  annulus  (23  ±  2
vs  23  ±  3  mm,  P  =  0.87)  and  the  sinuses  of  Valsalva  (33  ±  4
vs  34  ±  5  mm,  P  =  0.48).  There  was  also  a  trend  toward
a
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0rols and patients with patent foramen ovale (PFO). Bars represent
he 25th, 50th and 75th percentile values.
arger  proximal  ascending  aorta  diameters  in  patients  with
SA  compared  with  in  patients  with  isolated  PFO  (34  ±  vs
1  ±  4  mm,  P  =  0.11).
ntra- and interobserver variability
ntra-  and  interobserver  variabilities  at  the  levels  of  the
ortic  annulus,  the  sinuses  of  Valsalva  and  the  prox-
mal  ascending  aorta  were  0.7  ±  0.9  mm,  0.9  ±  1.1  mm
nd  0.7  ±  1.1  mm  and  0.8  ±  0.8  mm,  1.5  ±  1.3  mm  and
.6  ±  0.9  mm,  respectively.
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Table  1  Clinical  and  echocardiographic  characteristics  of  healthy  subjects  and  patients  with  patent  foramen  ovale.
Healthy  volunteers
(n  =  47)
Patients  with  patent
foramen  ovale  (n  =  47)
P
Age  (years) 35 ±  12  37  ±  7  0.3
Men  27  (57)  28  (60)  0.8
Height  (m)  1.72  ±  0.09  1.72  ±  0.10  0.9
Weight  (kg) 72 ±  11  74  ±  14  0.4
Body  surface  area  (kg/m2)  1.85 ±  0.16  1.88 ±  0.21  0.5
End-diastolic  left  ventricular  diameter 50 ±  4  48 ±  5  0.10
End-systolic  left  ventricular  diameter 32 ±  5  30 ±  4  0.04
Aortic  diameters
Aortic  annulus  22  ±  2  23  ±  3  0.2
Sinuses  of  Valsalva  31  ±  3  34  ±  4  <  0.01
Proximal  ascending  aorta  29  ±  3  32  ±  4  <  0.01
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size,  IAS  mobility,  degree  of  shunting  and  aortic  dimensions
in  patients  with  cryptogenic  CVA  with  and  without  PFO.  A
second  potential  explanation  for  our  ﬁndings  is  that  there
is  a  common  tissue  disorder  underlying  PFO,  ASA  and  aortic
dilatation.  Thus,  ASA  was  observed  almost  three  times  more
frequently  in  a  cohort  of  Marfan  patients  than  in  healthy
controls,  which  provides  evidence  that  the  presence  of  ASA
may  be  related  to  a  connective  tissue  disorder;  however,  the
prevalence  of  PFO  was  not  evaluated  [19]. Finally,  we  cannot
exclude  a  confounding  factor  among  PFO  patients  with  CVA
that  may  explain  aortic  dilatation.  We  tried  to  exclude  such
confounding  variables  by  excluding  older  PFO  patients  who
might  have  vascular  risk  factors  that  could  possibly  explain
both  the  CVA  and  aortic  dilatation.  In  this  regard,  it  should
be  emphasized  that  no  PFO  patient  or  healthy  control  was
hypertensive.
Figure 2. Schematic representation of the potential inﬂuence of
aortic dilatation on the occurrence of stroke. Continuous line: aValues are mean ± standard deviation or number of patients (perc
iscussion
ortic  diameters  at  the  levels  of  the  sinuses  of  Valsalva
nd  the  aortic  root  were  signiﬁcantly  greater  in  patients
ith  cryptogenic  CVA  and  PFO  than  in  matched  healthy  con-
rols.  The  size  of  the  difference  was  about  10%.  There  was
 trend  towards  an  increased  aortic  annulus  diameter  that
id  not  achieve  statistical  signiﬁcance.  These  differences
ere  speciﬁc  to  the  aorta  and  PFO  patients  had  similar  left
entricular  diameters.
PFO,  an  interatrial  connection  through  the  septum  secun-
um  that  persists  after  birth,  is  common,  with  an  incidence
f  about  25%  of  the  population  in  both  postmortem  [5]  and
chocardiographic  studies  [6].  ASA  refers  to  a  hypermobile
eptum  primum  portion  of  the  IAS,  present  in  2%  of  normal
ndividuals  and  associated  with  right-to-left  shunting  in  83%
4].  However,  despite  its  high  prevalence  and  potential  seri-
us  consequences,  adjunctive  factors  that  may  predispose
r  potentiate  the  risk  of  CVA  remain  unclear.
In  the  present  study,  we  observed  larger  aortic  dimen-
ions  in  patients  with  cryptogenic  CVA  and  PFO  than  in
ealthy  controls.  Dilatation  of  the  aortic  root  and  proxi-
al  ascending  aorta  may  increase  the  risk  of  right-to-left
hunting  by  changing  the  angulation  of  the  heart  in  such  a
ay  that  ﬂow  streaming  from  the  inferior  vena  cava  into
he  right  atrium  is  directed  more  towards  the  ostium  secun-
um  portion  of  the  IAS;  thrombotic  material  is  therefore
ore  likely  to  cross  into  the  systemic  circulation,  pos-
ibly  causing  a  CVA  (Fig.  2).  This  is  the  explanation  for
he  platypnoea-orthodeoxia  syndrome  and  the  association
etween  aneurismal  dilatation  of  the  ascending  aorta  and
assive  right-to-left  shunting  in  certain  postures  [10,13].
n  a  non-CVA  population,  the  aortic  root  diameter  has  been
ound  to  be  inversely  correlated  with  the  size  of  the  IAS.
s  the  IAS  basal  diameter  gets  smaller,  it  becomes  more
obile  and  more  prone  to  shunting  [18]. In  our  opinion,
hese  mechanistic  factors  are  the  most  plausible  explana-
ion  for  our  ﬁndings  and  it  is  worth  noting  that  patients
ith  massive  right-to-left  shunting  tend  to  have  larger  aor-
ic  dimensions.  In  the  present  study,  we  did  not  measure
AS  dimensions  but  they  would  be  of  interest  to  assess  in
 future  prospective  study  of  the  relationship  between  IAS
patient with normal aortic dimensions. Dotted line: a patient with
an enlarged ascending aorta responsible for increased interatrial
septum mobility and risk of paradoxical embolism. LA: left atrium;
RA: right atrium; RV: right ventricle.
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Several  limitations  of  the  present  study  need  to  be  under-
lined.  First,  only  patients  with  cryptogenic  CVA  and  PFO
were  enrolled  and  we  could  not  compared  aortic  dimensions
between  patients  with  and  without  PFO  or  with  patients  with
CVA  of  known  cause.  However,  with  regard  to  the  impor-
tant  prevalence  of  PFO  in  the  general  population,  we  expect
that  this  population  would  be  heterogeneous  and  that  a
large  sample  size  would  be  necessary.  Second,  controls  were
recruited  among  physicians  and  nurses  and  were  considered
as  healthy  based  on  medical  history  and  absence  of  symp-
toms  (and  normal  echocardiography).  No  contrast  study  was
performed  and  it  is  possible  that  some  of  them  may  have  had
PFO.  However,  exclusion  of  control  subjects  with  PFO  would
have  resulted  in  more  signiﬁcant  differences  between  the
groups.  Third,  a  high  proportion  of  ASA  was  observed  in  the
present  study  and  we  cannot  exclude  referral  bias.  Fourth,
we  have  no  clear  explanation  for  the  slightly  larger  left  ven-
tricular  diameters  in  PFO  patients  than  in  controls  despite
similar  BSAs,  but  the  difference  was  small.  Finally,  there
was  a  signiﬁcant  overlap  between  the  aortic  diameter  of
PFO  patients  and  healthy  controls  and  we  are  certainly  not
implying  that  CVA  in  PFO  is  only  related  to  aortic  size.  Fur-
thermore,  if  the  mean  difference  was  approximately  3  mm,
several  patients  had  signiﬁcantly  enlarged  aorta.  Therefore,
even  if  our  sample  size  is  limited  and  the  study  retrospec-
tive,  our  results  should  be  regarded  as  ‘‘proof  of  concept’’
or  as  preliminary  data  supporting  further  work  in  this  ﬁeld.
Conclusion
The  present  study  shows  that  aortic  diameter  is  increased  in
young  patients  with  cryptogenic  CVA  and  PFO  compared  with
in  matched  healthy  subjects.  Our  data  suggest  that  aortic
dilatation  may  potentiate  the  risk  of  cerebrovascular  events
in  patients  with  PFO.  These  preliminary  results  should  be
regarded  as  a  proof  of  concept  and  support  further  research
in  this  area.
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